v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in one reportable segment engaged in the design and sale of medical devices.
The accounting policies of the reportable segment are the same as those described in the summary of significant accounting policies. The Company's chief operating decision maker (“CODM”) assesses performance for the reportable segment and decides how to allocate resources primarily based on net (loss) income that is also reported on the condensed consolidated statements of comprehensive loss. The measure of segment assets is reported on the condensed consolidated balance sheets as total consolidated assets.
Net (loss) income is used to monitor budget versus actual results. The CODM also uses net (loss) income in competitive analysis by benchmarking to competitors. The competitive analysis along with the monitoring of budgeted versus actual results are used in assessing performance of the segment and in establishing management’s compensation.
Management has determined that Morgan Frank, Chief Executive Officer, is the CODM.
The following table sets forth the condensed consolidated statements of comprehensive (loss) income used by the CODM:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands)20262025
(As Restated)		20262025
(As Restated)
Revenue$9,739 $10,054 $19,358 $19,387 
Cost of Revenues2,315 2,206 4,502 4,164 
Gross Margin7,424 7,848 14,856 15,223 
Operating Expenses:
General and administrative4,902 4,368 10,152 9,211 
Selling and marketing1,923 1,674 4,322 3,205 
Research and development628 194 1,289 402 
Depreciation and amortization251 174 497 366 
Operating (Loss) Income(280)1,438 (1,404)2,039 
Total Other Expense, net(396)(887)(711)(7,606)
Net (Loss) Income Before Income Taxes(676)551 (2,115)(5,567)
Income tax expense6 - 6 - 
Net (Loss) Income$(682)$551 $(2,121)$(5,567)